Budesonide inhalation ameliorates endotoxin-induced lung injury in rabbits

Experimental Biology and Medicine

Volumn 240, Issue 12, 2015, Pages 1708-1716

  Gao, Wei ^a   Ju, Nanying ^b  

^a THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Budesonide; endotoxin; lung injury

Indexed keywords

BUDESONIDE; ENDOTOXIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 8; LEUKOCYTE ELASTASE; PROTEIN; TUMOR NECROSIS FACTOR ALPHA; GLUCOCORTICOID;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DYNAMIC COMPLIANCE; FRACTION OF INSPIRED OXYGEN; HISTOPATHOLOGY; INFLAMMATION; LEUKOCYTE COUNT; MALE; NEUTROPHIL COUNT; NONHUMAN; PARTIAL PRESSURE ARTERIAL OXYGEN; PEAK PRESSURE; RABBIT; RESPIRATORY TRACT PARAMETERS; SURVIVAL RATE; WET TO DRY WEIGHT RATIO; ANIMAL; BLOOD; CHEMICALLY INDUCED; DRUG EFFECTS; INHALATIONAL DRUG ADMINISTRATION; LUNG; PATHOLOGY; RESPIRATORY DISTRESS SYNDROME, ADULT;

ADMINISTRATION, INHALATION; ANIMALS; BUDESONIDE; ENDOTOXINS; GLUCOCORTICOIDS; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-8; LUNG; MALE; RABBITS; RESPIRATORY DISTRESS SYNDROME, ADULT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84958279828     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370215584938     Document Type: Article

References (36)

1. M.A.MatthayG.A.ZimmermanC.EsmonJ.BhattacharyaB.CollerC.M.DoerschukJ.FlorosM.A.GimbroneJrE.HoffmanR.D.HubmayrM.LeppertS.MatalonR.MunfordP.ParsonsA.S.SlutskyK.J.TraceyP.WardD.B.GailA.L.Harabin. Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med2003; 167: 1027–35.
2. M.BhatiaS.Moochhala. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol2004; 202: 145–56.
3. L.D.HudsonJ.A.MilbergD.AnardiR.J.Maunder. Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med1995; 151: 293–301.
4. H.E.MarshallE.N.PottsZ.T.KelleherJ.S.StamlerW.M.FosterR.L.Auten. Protection from lipopolysaccharide-induced lung injury by augmentation of airway S-nitrosothiols. Am J Respir Crit Care Med2009; 180: 11–8.
5. E.Abraham. Neutrophils and acute lung injury. Crit Care Med2003; 31: S195–9.
6. J.ReutershanA.BasitE.V.GalkinaK.Ley. Sequential recruitment of neutrophils into lung and bronchoalveolar lavage fluid in LPS-induced acute lung injury. Am J Physiol Lung Cell Moll Physiol2005; 289: L807–15.
7. M.B.EverhartW.HanT.P.SherrillM.ArutiunovV.V.PolosukhinJ.R.BurkeR.T.SadikotJ.W.ChristmanF.E.YullT.S.Blackwell. Duration and intensity of NF-kappaB activity determine the severity of endotoxin-induced acute lung injury. J Immunol2006; 176: 4995–5005.
8. G.Y.ParkJ.W.Christman. Nuclear factor kappa B is a promising therapeutic target in inflammatory lung disease. Curr Drug Target2006; 7: 661–8.
9. M.D.SchwartzE.E.MooreF.A.MooreR.ShenkarP.MoineJ.B.HaenelE.Abraham. Nuclear factor-kappa B is activated in alveolar macrophages from patients with acute respiratory distress syndrome. Crit Care Med1996; 24: 1285–92.
10. M.KarinM.Delhase. The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. Semin Immunol2000; 12: 85–98.
11. P.R.RoccoA.B.SouzaD.S.FaffeC.P.PassaroF.B.SantosE.M.NegriJ.G.LimaR.S.ContadorV.L.CapelozziW.A.Zin. Effect of corticosteroid on lung parenchyma remodeling at an early phase of acute lung injury. Am J Respir Crit Care Med2003; 168: 677–84.
12. P.L.SilvaC.S.GarciaP.A.MaronasV.R.CagidoE.M.NegriN.R.Damaceno-RodriguesG.M.VenturaP.T.BozzaW.A.ZinV.L.CapelozziP.PelosiP.R.Rocco. Early short-term versus prolonged low-dose methylprednisolone therapy in acute lung injury. Eur Respir J2009; 33: 634–45.
13. R.I.ScheinmanA.GualbertoC.M.JewellJ.A.CidlowskiA.S.BaldwinJr. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors. Mol Cell Biol1995; 15: 943–53.
14. N.AuphanJ.A.DiDonatoC.RosetteA.HelmbergM.Karin. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science (New York, NY)1995; 270: 286–90.
15. J.V.PeterP.JohnP.L.GrahamJ.L.MoranI.A.GeorgeA.Bersten. Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis. BMJ2008; 336: 1006–9.
16. J.WangL.ZhangS.M.Walther. Inhaled budesonide in experimental chlorine gas lung injury: influence of time interval between injury and treatment. Intens Care Med2002; 28: 352–7.
17. D.MokraJ.MokryA.DrgovaM.PetraskovaJ.BulikovaA.Calkovska. Intratracheally administered corticosteroids improve lung function in meconium-instilled rabbits. J Physiol Pharmacol2007; 58: 389–98.
18. M.KohnoM.HaramotoO.NakajimaL.YangS.HinotsuM.YokohiraK.ImaidaK.Kawakami. Antedrug budesonide by intrapulmonary treatment attenuates bleomycin-induced lung injury in rats with minimal systemic adverse effects. Biol Pharm Bull2010; 33: 1206–11.
19. A.H.JanssonC.ErikssonX.Wang. Effects of budesonide and N-acetylcysteine on acute lung hyperinflation, inflammation and injury in rats. Vasc Pharmacol2005; 43: 101–11.
20. D.C.AngusW.T.Linde-ZwirbleJ.LidickerG.ClermontJ.CarcilloM.R.Pinsky. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Critical Care Med2001; 29: 1303–10.
21. P.VillaP.Ghezzi. Animal models of endotoxic shock. Meth Mol Med2004; 98: 199–206.
22. R.A.PauwelsS.PedersenW.W.BusseW.C.TanY.Z.ChenS.V.OhlssonA.UllmanC.J.LammP.M.O'Byrne. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet2003; 361: 1071–6.
23. A.L.ShefferM.SilvermanA.J.WoolcockP.V.DiazB.LindbergB.Lindmark. Long-term safety of once-daily budesonide in patients with early-onset mild persistent asthma: results of the Inhaled Steroid Treatment as Regular Therapy in Early Asthma (START) study. Ann Allergy, Asthma Immunol: Official publication of the American College of Allergy, Asthma, & Immunology2005; 94: 48–54.
24. C.E.BrightlingR.WardA.J.WardlawI.D.Pavord. Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis. Eur Respir J2000; 15: 682–6.
25. N.Y.JuH.GaoW.HuangF.F.NiuW.X.LanF.LiW.Gao. Therapeutic effect of inhaled budesonide (Pulmicort(R) Turbuhaler) on the inflammatory response to one-lung ventilation. Anaesthesia2014; 69: 14–23.
26. S.FujishimaH.MorisakiA.IshizakaY.KotakeM.MiyakiK.YohK.SekineJ.SasakiS.TasakaN.HasegawaY.KawaiJ.TakedaN.Aikawa. Neutrophil elastase and systemic inflammatory response syndrome in the initiation and development of acute lung injury among critically ill patients. Biomed Pharmacother2008; 62: 333–8.
27. K.KawabataT.HagioS.MatsumotoS.NakaoS.OritaY.AzeH.Ohno. Delayed neutrophil elastase inhibition prevents subsequent progression of acute lung injury induced by endotoxin inhalation in hamsters. Am J Respir Crit Care Med2000; 161: 2013–8.
28. R.B.GoodmanJ.PuginJ.S.LeeM.A.Matthay. Cytokine-mediated inflammation in acute lung injury. Cytokine Growth Factor Rev2003; 14: 523–35.
29. A.L.DunicanS.J.LeuenrothP.GrutkoskiA.AyalaH.H.Simms. TNFalpha-induced suppression of PMN apoptosis is mediated through interleukin-8 production. Shock2000; 14: 284–8; discussion 8-9.
30. J.GuanD.D.JinL.J.JinQ.Lu. Apoptosis in organs of rats in early stage after polytrauma combined with shock. J Trauma2002; 52: 104–11.
31. S.J.WilsonA.WallinG.Della-CioppaT.SandstromS.T.Holgate. Effects of budesonide and formoterol on NF-kappaB, adhesion molecules, and cytokines in asthma. Am J Respir Crit Care Med2001; 164: 1047–52.
32. F.M.SpoelstraD.S.PostmaH.HovengaJ.A.NoordhoekH.F.Kauffman. Budesonide and formoterol inhibit ICAM-1 and VCAM-1 expression of human lung fibroblasts. Eur Respir J2000; 15: 68–74.
33. A.OberholzerC.OberholzerL.L.Moldawer. Cytokine signaling–regulation of the immune response in normal and critically ill states. Crit Care Med2000; 28: N3–12.
34. M.JohnS.LimJ.SeyboldP.JoseA.RobichaudB.O'ConnorP.J.BarnesK.F.Chung. Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1alpha, granulocyte-macrophage colony-stimulating factor, and interferon-gamma release from alveolar macrophages in asthma. Am J Respir Crit Care Med1998; 157: 256–62.
35. F.LiuJ.PauluhnH.TrubelC.Wang. Single high-dose dexamethasone and sodium salicylate failed to attenuate phosgene-induced acute lung injury in rats. Toxicology2014; 315: 17–23.
36. G.Matute-BelloC.W.FrevertT.R.Martin. Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol2008; 295: L379–99.